- Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
- Innoviva to Participate in the BofA Securities Health Care Conference
- Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Key statistics
On Monday, Innoviva Inc (INVA:NSQ) closed at 15.90, -5.72% below its 52-week high of 16.87, set on Jan 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.85 |
---|---|
High | 16.02 |
Low | 15.70 |
Bid | 12.46 |
Offer | 19.79 |
Previous close | 15.90 |
Average volume | 376.95k |
---|---|
Shares outstanding | 62.44m |
Free float | 61.86m |
P/E (TTM) | 7.21 |
Market cap | 986.00m USD |
EPS (TTM) | 2.19 USD |
Data delayed at least 15 minutes, as of Jun 03 2024 21:00 BST.
More ▼